NCT03340389 is a NA clinical trial of a ray-tracing aberrometry in Age-related Cataract, sponsored by Wenzhou Medical University.

Who is sponsoring NCT03340389?

NCT03340389 is sponsored by Wenzhou Medical University.

What drugs are being tested in NCT03340389?

Interventions in NCT03340389: a ray-tracing aberrometry.

What condition does NCT03340389 study?

NCT03340389 studies Age-related Cataract.

Is NCT03340389 still recruiting?

NCT03340389 is currently status unknown. Last updated 13 November 2017.

Last reviewed 2017-11-13 · How we verify

NCT03340389

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dysfunctional Lens Index Serves as a Novel Surgery Decision Maker for Age-related Cataracts

Status unknown NA Last updated 13 November 2017

What this trial tests

NA trial testing a ray-tracing aberrometry in Age-related Cataract in 60 participants. Status unknown.

Timeline

1 September 2017

Primary endpoint
1 May 2018

1 December 2018

Quick facts

Lead sponsor	Wenzhou Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	60
Start date	1 September 2017
Primary completion	1 May 2018
Estimated completion	1 December 2018
Sites	1 location across China

Drugs / interventions tested

a ray-tracing aberrometry

Conditions studied

Age-related Cataract — all drugs for Age-related Cataract →

Sponsor

Wenzhou Medical University

Who can join

Eligibility, any sex, with Age-related Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To study the correlations among the dysfunctional lens index (DLI), Lens Opacities Classification System III (LOCS III) nuclear opalescence grading score, preoperative corrected distance visual acuity (CDVA), the objective scatter index (OSI) and Scheimpflug based average lens density in age-related cataracts. To investigate the potential of the DLI as a novel surgery decision maker via the Operating Characteristic (ROC) curve analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Wenzhou Medical University trials

Trials by the same sponsor.

NCT06905938 — Comparing Monofocal IOLs in Highly Myopic Cataract Patients · not yet recruiting
NCT06892470 — Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses · active not recruiting
NCT06751342 — Using Psychophysics Methods to Investigate Sensory Dominance After Cataract Surgery · active not recruiting
NCT06707740 — Comparison of the Effect of Capsular Bend on the Rotational Stability Between Two Toric Intraocular Lenses · active not recruiting
NCT06091722 — Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03340389 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wenzhou Medical University
Last refreshed: 13 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03340389.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing